Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA- (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo.

29 Oct 2013

Viewpoints: Sen. Sanders says don't cut entitlements before making corporations pay taxes; Rep. Smith argues that if entitlements are tamed, other priorities will suffer

Instead of talking about cuts in Social Security, Medicare and Medicaid, we must end the absurdity of corporations not paying a nickel in federal income taxes. A 2008 report from the Government Accountability Office found that was the case with 1 in 4 large U.S. corporations. At a time when multinational corporations and the wealthy are avoiding an estimated $100 billion a year in taxes by stashing money in tax havens like the Cayman Islands, we need to make them pay taxes just as middle-class Americans do (Sen. Bernie Sanders, I-Vt., 10/28).

29 Oct 2013

VisionGate's Cell-CT platform can detect lung cancer in sputum samples with high specificity

VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT-, can detect lung cancer in sputum samples with high sensitivity and specificity. The data was presented at the International Association for the Study of Lung Cancer 15th World Conference on Lung Cancer.

29 Oct 2013

COPD–asthma overlap heightens exacerbation risk

Patients with chronic obstructive pulmonary disease and concomitant asthma have significantly more exacerbations and hospitalizations than patients with COPD alone, research shows.

28 Oct 2013

Rituximab drug may be safe, effective for immunoglobulin G4-related disease treatment

Rituximab (Rituxan) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener's), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

Bad news for women with sleep apnea: The body's autonomic responses more diminished in women

There's more bad news for women with sleep apnea. A new study from the UCLA School of Nursing shows that the body's autonomic responses - the controls that impact such functions as blood pressure, heart rate and sweating - are weaker in people with obstructive sleep apnea but are even more diminished in women.

25 Oct 2013

Common food additive can block new strain of avian influenza virus

A common food additive can block a deadly new strain of avian influenza virus from infecting healthy cells, report researchers at the University of Illinois at Chicago College of Medicine in the online journal, PLOS ONE.

24 Oct 2013

Pertussis incidence: an interview with Leonard Friedland, M.D., V.P. and Director of Scientific Affairs and Public Health for GSK Vaccines

Distinguishing pertussis (also known as whooping cough) from other respiratory illnesses is challenging in particular among adults because the signs and symptoms of pertussis overlap with those of other respiratory diseases.

24 Oct 2013

FDA to phase out all inhaler medical products containing CFCs by Dec. 31

The U.S. Food and Drug Administration will complete its phase-out of all inhaler medical products containing chlorofluorocarbons by Dec. 31, 2013. This effort is to comply with an international treaty to protect the ozone layer by phasing out the worldwide production of numerous substances, including CFCs, which contribute to ozone depletion.

24 Oct 2013

Elderly people at increased risk for getting flu

Flu season lurks around the corner throughout the United States, and gerontologists at the University of Alabama at Birmingham say the elderly are at increased risk for getting the flu and often have a worse time coping with flu symptoms than do younger people.

24 Oct 2013

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Diffregen LLC, a Temple University startup company, has been awarded a small business innovation research Phase 1 grant by the National Cancer Institute to advance Angiocidin, a university-created therapeutic to treat acute myeloid leukemia, to the doorstep of human clinical trials.

24 Oct 2013

New flu vaccine offers better protection against circulating flu viruses

Last year's flu season was considered one of the strongest and deadliest in recent decades, according to the CDC. In preparation for this year's flu season, Concentra, a subsidiary of Humana Inc., offers a flu vaccine to provide greater protection against circulating flu strains.

23 Oct 2013

Tissue-engineered transplants safe and effective in the long term: Study

New results published in The Lancet today [Wednesday 23 October] reveal that five years after the first successful transplantation of a tissue-engineered airway (reported in The Lancet in 2008) the recipient continues to enjoy a good quality of life, and has not experienced any immunological complications or rejection of the implanted airway.

23 Oct 2013

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

The flu vaccine may not only ward off serious complications from influenza, it may also reduce the risk of heart attack or stroke by more than 50 per cent among those who have had a heart attack, according to new research led by Dr. Jacob Udell, a cardiologist at Women's College Hospital and clinician-scientist at the University of Toronto. What's more, the vaccine's heart protective effects may be even greater among those who receive a more potent vaccine.

23 Oct 2013

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Receiving an influenza vaccination was associated with a lower risk of major adverse cardiovascular events such as heart failure or hospitalization for heart attack, with the greatest treatment effect seen among patients with recent acute coronary syndrome (ACS; such as heart attack or unstable angina), according to a meta-analysis published in the October 23/30 issue of JAMA.

23 Oct 2013

Climate change associated with increased mortality, especially during extremely hot periods

The increased temperatures caused by ongoing climate change in Stockholm, Sweden between 1980 and 2009 caused 300 more premature deaths than if the temperature increase did not take place.

23 Oct 2013

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

EvergreenHealth today announced it has earned several distinctions for 2014 across many of the health care system's specialties from Healthgrades, the nation's leading independent provider of information to help consumers make informed decisions about a physician or hospital.

23 Oct 2013

Cedars-Sinai wins national consumer award for providing quality medical care, staff in LA region

For the 18th year in a row, Cedars-Sinai has won a national consumer award for providing the highest quality medical care and staff in the Los Angeles region based on a survey of area households.

22 Oct 2013

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

A study led by St. Jude Children's Research Hospital scientists highlights a new approach for developing a universal influenza vaccine that could protect against multiple flu strains, including deadly pandemic strains. The research appears today in the advance online edition of the scientific journal Nature Immunology.

22 Oct 2013

FDA approves SC formulation of Genentech's Actemra for rheumatoid arthritis

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of Actemra (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis who have used one or more disease-modifying antirheumatic drugs, such as methotrexate, that did not provide enough relief.

22 Oct 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

Viewpoints: Sen. Sanders says don't cut entitlements before making corporations pay taxes; Rep. Smith argues that if entitlements are tamed, other priorities will suffer

VisionGate's Cell-CT platform can detect lung cancer in sputum samples with high specificity

COPD–asthma overlap heightens exacerbation risk

Rituximab drug may be safe, effective for immunoglobulin G4-related disease treatment

Bad news for women with sleep apnea: The body's autonomic responses more diminished in women

Common food additive can block new strain of avian influenza virus

Pertussis incidence: an interview with Leonard Friedland, M.D., V.P. and Director of Scientific Affairs and Public Health for GSK Vaccines

FDA to phase out all inhaler medical products containing CFCs by Dec. 31

Elderly people at increased risk for getting flu

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

New flu vaccine offers better protection against circulating flu viruses

Tissue-engineered transplants safe and effective in the long term: Study

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Climate change associated with increased mortality, especially during extremely hot periods

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

Cedars-Sinai wins national consumer award for providing quality medical care, staff in LA region

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

FDA approves SC formulation of Genentech's Actemra for rheumatoid arthritis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in